Literature DB >> 1706681

Antigen recognition and peptide-mediated immunotherapy in autoimmune disease.

D E Smilek1, C B Lock, H O McDevitt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1706681     DOI： 10.1111/j.1600-065x.1990.tb00813.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN： 0105-2896            Impact factor:   12.988


× No keyword cloud information.
  7 in total

Review 1.  Approaches toward peptide-based immunotherapy of autoimmune diseases.

Authors:  L Adorini; J C Guéry; S Trembleau
Journal:  Springer Semin Immunopathol       Date:  1992

2.  Copolymer 1 acts against the immunodominant epitope 82-100 of myelin basic protein by T cell receptor antagonism in addition to major histocompatibility complex blocking.

Authors:  R Aharoni; D Teitelbaum; R Arnon; M Sela
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

Review 3.  Modulation of the immune response with T-cell epitopes: the ultimate goal for specific immunotherapy of autoimmune disease.

Authors:  P J Fairchild; C J Thorpe; P J Travers; D C Wraith
Journal:  Immunology       Date:  1994-04       Impact factor: 7.397

4.  Polymorphism of the human immunoglobulin variable region segment V1-4.1.

Authors:  E K Shin; F Matsuda; S Ozaki; S Kumagai; O Olerup; H Ström; I Melchers; T Honjo
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

5.  Identification of a pathogenic epitope involved in initiation of Heymann nephritis.

Authors:  D Kerjaschki; R Ullrich; K Diem; S Pietromonaco; R A Orlando; M G Farquhar
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

6.  Selective immunosuppression by administration of major histocompatibility complex (MHC) class II-binding peptides. I. Evidence for in vivo MHC blockade preventing T cell activation.

Authors:  J C Guéry; A Sette; J Leighton; A Dragomir; L Adorini
Journal:  J Exp Med       Date:  1992-05-01       Impact factor: 14.307

7.  A peptide-binding motif for I-A(g7), the class II major histocompatibility complex (MHC) molecule of NOD and Biozzi AB/H mice.

Authors:  L C Harrison; M C Honeyman; S Trembleau; S Gregori; F Gallazzi; P Augstein; V Brusic; J Hammer; L Adorini
Journal:  J Exp Med       Date:  1997-03-17       Impact factor: 14.307
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.